Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
Clinical trial NCT00894686 · COMPLETED
Trial details
- NCT number
- NCT00894686
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-26
- Primary completion
- 2017-05-10
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.